October 29, 2026

HPA-Global regulatory strategic partner CIRS Group has supported Chinese health technology company Magic Health in completing a U.S. Self-GRAS assessment for its PERFQUQ™ pyrroloquinoline quinone disodium salt (PQQ).
According to CIRS, an independent panel of qualified scientific experts unanimously concluded that PERFQUQ is Generally Recognized as Safe under its intended conditions of use in foods and beverages in the United States. CIRS provided regulatory support throughout the GRAS assessment process.
The milestone represents an important step in Magic Health’s international expansion and provides the company with a regulatory pathway for introducing its PQQ ingredient into the U.S. food and functional nutrition market.
PERFQUQ is manufactured using a proprietary microbial fermentation process that incorporates fermentation, extraction and purification technologies. The company says its manufacturing system includes quality controls covering strain selection, fermentation, purification, refining and finished-product testing.
The ingredient is designed for use in a variety of finished-product formats, including powders, tablets and functional beverages.
Magic Health also markets a sustained-release technology called PQQ-BAup, designed to provide gradual delivery of PQQ over an extended period. According to the company, testing of the technology demonstrated release for up to 12 hours.
PQQ has attracted increasing attention within the global nutrition industry because of its relationship with mitochondrial function and cellular energy metabolism. The ingredient is being explored in product categories including healthy aging, cognitive health, sports nutrition, cardiovascular health and beauty-from-within.
Magic Health Technology Co., Ltd. was established in 2021 and was jointly invested in by Huadong Medicine and Angel Group. The company focuses on functional nutritional ingredients as well as active ingredients for personal care and medical aesthetic applications.
What This Means for the Industry
The development is another example of Chinese functional ingredient companies pursuing regulatory pathways that support expansion into international markets.
For Chinese ingredient manufacturers, establishing Self-GRAS status can provide an important foundation for commercial discussions with U.S. food, beverage and nutrition companies that require documented safety assessments before considering new ingredients.
The activity surrounding PQQ is also notable because the ingredient sits within several rapidly developing nutrition categories, particularly healthy aging, mitochondrial health and energy metabolism.
For international companies sourcing functional ingredients from China, the growing number of Chinese manufacturers pursuing U.S. regulatory assessments may increase access to new suppliers while also raising expectations around safety documentation, manufacturing quality and regulatory preparedness.
It is important to distinguish Self-GRAS from an FDA GRAS notification and “no questions” letter. In this case, the GRAS conclusion was reached by an independent expert panel and was not described by CIRS as an FDA-reviewed GRAS notice.
Source: CIRS Group
https://www.cirs-group.com/en/food/cirs-supports-magic-health-in-securing-us-gras-for-pqq
For more details, visit: www.hpaglobal.org/connect